Evaluation of the Effectiveness of Immersive Virtual Reality Therapy as a Method Supporting the Cardiac Rehabilitation
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Cardiovascular Diseases
- Sponsor
- Wroclaw University of Health and Sport Sciences
- Enrollment
- 34
- Locations
- 2
- Primary Endpoint
- Hospital Anxiety and Depression Scale (HADS)
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
This study evaluates the effectiveness of virtual reality (VR) therapy in the treatment of depression and anxiety symptoms in patients undergoing second stage of cardiac rehabilitation. Half of the study group will receive VR therapy (VR group) as an addition to cardiologically monitored physical training. The other half of the group (control group) will receive Schultz Autogenic Training as a standard supplement to cardiological training.
Detailed Description
Cardiologically monitored physical training in second stage of cardiac rehabilitation leads to the improvement in the physical capacity and overall fitness of the patients with Coronary Artery Disease, allowing restoration of independence in daily functioning. Psychological support is required in order to reduce the negative psychological symptoms related to both the heart disease itself and the cardiac surgery performed. In this study the investigators want to assess the effectiveness of the virtual reality (VR) therapy compared to standard psychological support (Schultz Autogenic Training). Thanks to using head mounted display and the phenomenon of total immersion VR therapy allows to completely separate the patient from the hospital environment, provides an intense visual, auditory and kinesthetic stimulation. Depending on the stage of therapy it can have a calming and mood-improving effect or, in another part of the therapy, it can motivate the patient to the rehabilitation process. The additional aim of the VR therapy is to help the patients regain their emotional balance, let them recognize their psychological resources and trigger the natural recovery mechanisms. The goals of the project: 1. The evaluation of the influence of VR therapy on the depressive symptoms and the anxiety level of the patients undergoing second stage of cardiac rehabilitation. 2. The evaluation of the influence of VR therapy on the stress level of the patients undergoing second stage of cardiac rehabilitation.
Investigators
Joanna Szczepańska-Gieracha
professor
Wroclaw University of Health and Sport Sciences
Eligibility Criteria
Inclusion Criteria
- •Coronary Artery Disease;
- •the second stage of cardiac rehabilitation conducted in outpatient settings;
- •anxiety symptoms scored 8 and more in HADS-A or depressive symptoms scored 8 and more in HADS-D.
Exclusion Criteria
- •cognitive impairment (MMSE\<24);
- •inability to self-complete the research questionnaires;
- •presence of the following issues at the time of the examination or in the medical data: disturbances of consciousness, psychotic symptoms or other serious psychiatric disorders;
- •initiation of psychiatric treatment during the research project;
- •contraindications for virtual therapy (epilepsy, vertigo, eyesight impairment);
- •the patient's refusal at any stage of the research project.
Outcomes
Primary Outcomes
Hospital Anxiety and Depression Scale (HADS)
Time Frame: 15 minutes
The Hospital Anxiety and Depression Scale (HADS) is a fourteen-item scale scoring from 0 to 3 for each item. The first seven items relate to anxiety (HADS-A), and the remaining seven items relate to depression (HADS-D). The global scoring ranges from 0 to 42 with a cut-off point of 8/21 for anxiety and 8/21 for depression. The higher the score, the greater anxiety or depression symptoms. HADS will be performed at the beginning and after four weeks of treatment.
Secondary Outcomes
- Perception of Stress Questionnaire (PSQ)(30 minutes)